Author: Ken Dropiewski

Siemens Healthineers introduces Somatom Confidence RT Pro CT Scanner

Erlangen, 2016-Sep-27 Somatom Confidence RT Pro is a dedicated CT for radiation therapy DirectDensity algorithm delivers electron density images independent of kV settings, ensuring a smooth simple dose calculation workflow New version of syngo.via RT Image Suite software offers advanced treatment of moving tumors Siemens Healthineers introduced its new Somatom […]

Biotech Pioneer BIOLIFE4D Submits Regulation A+ Filing with SEC for up to $50 Million Initial Public Offering

CHICAGO, Sept. 7, 2017 /PRNewswire/ — BIOLIFE4D announced it filed a $50 million initial public offering with the Securities and Exchange Commission (SEC) under Regulation A+ rules, allowing everyday investors to help the company bring its groundbreaking cardiac tissue regeneration and organ replacement process to market. Chicago-based BIOLIFE4D is a pioneering biotech company focused on leveraging […]

BioCardia Receives U.S. Patent Covering A Method Of Preparing And Characterizing Mesenchymal Cells, Providing Further Protection To Cardiallo Cell Therapy Program

SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia®, Inc. [OTC:BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, with clinical programs in heart failure and sub-acute infarction, today announced the issuance of United States Patent No. 9,301,975 relating to a method of producing mesenchymal stem cells from bone marrow cells in […]

Johnson & Johnson Medical Devices Companies Signals Commitment to Stroke Treatment With the Announcement of New Neurovascular Business

NICE, France, September 7, 2017 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* today introduced CERENOVUS,** its new neurovascular business, at the European Society of Minimally Invasive Neurological Therapy (ESMINT) 9th Annual Meeting. CERENOVUS, a name derived from the Latin words for ‘new’ and ‘brain’, will focus on delivering innovative therapies for hemorrhagic […]

VentureMed Group Appoints New VP Of Sales And Marketing

TOLEDO, Ohio, Sept. 5, 2017 /PRNewswire/ — VentureMed Group, Inc., (“VMG” or the “Company”) a medical device company focused on developing and commercializing next-generation endovascular devices to treat peripheral arterial disease (PAD), announced today the appointment of Dave Cox as Vice President of Sales and Marketing. In this role, Mr. Cox will be responsible for […]

Gardia Medical Demonstrates Enhanced Safety in Lower Extremity Interventions

CAESAREA, Israel, Sept. 6, 2017 /PRNewswire/ — Gardia Medical, an Israeli Medical Device Company focused on embolic protection solutions, announced that according to the independent Clinical Events Committee (CEC), Gardia successfully met the primary end-point in its WISE-LE study. The WISE-LE study’s objective is to demonstrate the safety and performance of the […]

New Research Confirms Significance of AliveCor’s 30 Second EKG

MOUNTAIN VIEW, Calif., Sept. 6, 2017 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (EKG) technology, today announced the results of four clinical research presentations that demonstrate that AliveCor’s hyper-fast, 30 second, digital EKG can positively impact and potentially even save the lives of millions of people around the world who suffer […]

Cerebrotech Appoints Neurovascular Veteran Martin Dieck to Executive Chairman

PLEASANTON, Calif.–(BUSINESS WIRE)–Cerebrotech Medical Systems, an innovative medical device company focused on the development of a portable brain bioimpedance monitor, today announced that board member Martin Dieck, an experienced entrepreneur with expertise in developing novel neurovascular solutions, will step up to executive chairman, effectively immediately. “I am thrilled to have […]

Cardiac Insight, Inc. Continues Steady Beat of Progress with New $4.5 Million Investment and Attracts Prestigious Healthcare M&A Executive, Clifford J. Stocks, to Its Board of Directors

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a U.S. developer of wearable medical devices and diagnostic software, announced today that the company continues to experience a steady beat of market traction and industry endorsement with a recent infusion of $4.5 million into their new C-1 round of funding, currently capped at $10 […]